Personalized Medicine Conference cordially invites Researchers, physicians, Genomics associations and Public Healthcare Professionals from all over the globe to be present at “Personalized Medicine and Novel Therapy" which is going to be held during September 09-10, 2024 at Paris, France. Personalized Medicine Conference based on the theme “Patient-Centric Paradigm: Redefining Healthcare Delivery through Personalized Medicine and Novel Therapies" is going to be an extraordinary event which will focus on the recent medical developments in the fields of Personalized Medicine, Personalized drug and Personalized Cancer.

Why join LONGDOM Conferences?
Understand the current state of research | Meet international colleagues and experts | Visit the exhibition of leading-edge technology | Engage with editors of the top journals in your field | Global networking and certification | Brand launching and many more to explore

Target Audience:
Target audience are Physicians, Licensed Practical Nurse, Industry Professionals, Research Scholars, Healthcare Professionals Diagnostic laboratory professionals, Business Entrepreneurs, Directors & CEO’s of Organizations, Hospitals, Microbiologists, Pharmaceutical Industries, Nurse Practitioners.

Scientific Sessions

Session 1: Personalized Medicine

Personalized medicine is a multi-faceted way to deal with patient consideration that not just improves our capacity to analyse and treat illness, yet offers the possibility to identify sickness at a prior stage when it is simpler to treat adequately. The Personalized drug gives a chance to create operators that are focused on patient gatherings that don't react to prescriptions as proposed and for whom the conventional wellbeing frameworks have generally fizzled. The fruitful routine with regards to Personalized medication requires changes by and by examples and the board methodologies for social insurance experts just as for producers in repayment, administrative practices and information sharing.

Session 2: Personalized medicine: Drug discovery and patient care

Personalized medicine, the use of marker-assisted diagnosis and targeted therapies derived from an individual's molecular profile, will impact the way drugs are developed and medicine is practiced. Knowledge of the molecular basis of disease will lead to novel target identification, toxic genomic markers to screen compounds and improved selection of clinical trial patients, which will fundamentally change the pharmaceutical industry. The traditional linear process of drug discovery and development will be replaced by an integrated and heuristic approach. In addition, patient care will be revolutionized through the use of novel molecular predisposition, screening, diagnostic, prognostic, pharmacogenomics and monitoring markers. Although numerous challenges will need to be met to make personalized medicine a reality, with time, this approach will replace the traditional trial-and-error practice of medicine.

Session 3: Individualized Treatment through Personalized Medicine

This perspective addresses conceptual approaches that can be undertaken to develop and apply clinical decision support in electronic health record systems to achieve personalized medical care. In addition, to represent meaningful benefits to personalized decision-making, a comparison of current and future applications of clinical decision support to enable individualized medical treatment plans is presented. If clinical decision support tools are to impact outcomes in a clear and positive manner, their development and deployment must therefore consider the needs of the providers, including specific practice needs, information workflow, and practice environment.

Session 4: Genomic Profiling and Pharmacogenomics

Genomic profiling plays a central role in personalized medicine by providing detailed information about an individual's genetic makeup, which can be used to tailor medical care to their specific needs and Pharmacogenomics, a key component of personalized medicine, focuses on understanding how an individual's genetic makeup influences their response to medications. By analysing genetic variations that affect drug metabolism, efficacy, and adverse reactions, pharmacogenomics enables healthcare providers to tailor medication regimens to each patient's unique genetic profile.

Session 5: Preventive Medicine & Public Health Care

Preventive Medicine is sharpened by all specialists to keep their patients sound. It is also an extraordinary therapeutic distinguishing strength saw by the American Board of Medical Specialties (ABMS). Preventive Medicine focuses on the prosperity of individuals, gatherings, and portrayed peoples. It is similarly used for the treatment for strength, visual hindrance. The Epidemiology Division applies inquire about systems to illustrations and explanations behind prosperity and affliction in the people and to make a translation of this learning into ventures proposed to turn away disease. The division has a long history of consideration in NIH-bolstered multi-site, longitudinal accomplice studies, and its staff deal with various pro began, NIH-upheld investigation endeavours and trials. Open trust in antibodies is a key to the accomplishment of immunization ventures worldwide in the time of preventive solution. The focus of Preventive Medicine and Public Health is health of individuals, communities, and defined populations. To, maintain health and protect, promote and to prevent disease, death and disability. The result of Public health surveillance is the identification and prioritization of public health issues the world is facing today, including HIV/AIDS, antibiotic resistance, diabetes, zoonotic diseases, and waterborne diseases. Preventive Medicine and Public health incorporates the interdisciplinary approaches of epidemiology, biostatistics and health services.

Session 6: Precision Diagnosis

Precision diagnosis refers to the use of advanced technologies, techniques, and knowledge to accurately identify diseases or conditions in individuals. It aims to move beyond traditional diagnostic methods, which may rely solely on symptoms and general tests, to provide more personalized and effective healthcare. Precision diagnosis represents a shift towards a more personalized and precise approach to healthcare, with the potential to revolutionize how diseases are diagnosed and treated.

Session 7: Personalized Medicine for diseases

Personalized medicine represents a paradigm shift in healthcare towards more precise, individualized approaches to disease prevention, diagnosis, and treatment. By harnessing the power of genetics, biomarkers, and advanced technology, personalized medicine holds the promise of improving patient outcomes, reducing healthcare costs, and transforming the practice of medicine. It includes:

Onology
Cardiovascular
CNS Disease

Session 8: Targeted Therapies

Targeted therapies are a type of treatment that specifically targets the molecular alterations or pathways that drive the growth and spread of cells. This approach often leads to fewer side effects and improved outcomes for patients. Some of the targeted therapies are:

Immunotherapy
Gene Therapy
RNA- based Therapeutics
Stem cell Therapy

Session 9: Personalized Vaccinology

Vaccinology is to determine and develop extremely immunogenic and safe vaccines that protect against infectious and non-infectious i.e., cancers diseases but it is failure till date because of both pathogen and host variability. For hyper-variable viral pathogens like HIV, HCV and rhinovirus it has been unable to discover and develop highly immunogenic vaccine. Host variability is evident in the multiplicity of immune response genes that encode >1012 products necessary for generating immune responses i.e., antibodies and T cell receptors.

Session 10: Nanomedicine

Nanomedicine is the medical application of nanotechnology. The ethics of personalized medicine can help to design the Nanodrug to be as effective as possible for each patient. Personalized medicine is a massive development in the advanced restorative medical world. Nanomedication ranges from the medical applications of nanomaterials and biological devices to nanoelectronic biosensors, and even probable future applications of molecular nanotechnology such as biological machines.

Session 11: Personalized medicine: Drug discovery and patient care

Advances in human genome research are opening the door to a new paradigm for practicing medicine that promises to transform healthcare. Personalized medicine, the use of marker-assisted diagnosis and targeted therapies derived from an individual's molecular profile, will impact the way drugs are developed and medicine is practiced. Knowledge of the molecular basis of disease will lead to novel target identification, toxic genomic markers to screen compounds and improved selection of clinical trial patients, which will fundamentally change the pharmaceutical industry. The traditional linear process of drug discovery and development will be replaced by an integrated and heuristic approach. In addition, patient care will be revolutionized through the use of novel molecular predisposition, screening, diagnostic, prognostic, pharmacogenomics and monitoring markers. Although numerous challenges will need to be met to make personalized medicine a reality, with time, this approach will replace the traditional trial-and-error practice of medicine.

Session 12: Globalization and Health

The procedures of globalization are making new threats to health care and its determinants. Medical problems that rise above national limits incorporate natural corruption and environmental change, disparity and way of life style changes, access to medicines and public health knowledge also additionally new and re-emerging diseases. We encourage participants from technological, community, clinical groups and individual perspectives. We inspire authors to arrange their papers with in global congress significant to their theme; to scrutinize business as usual and innovate new possibilities for public health globally. We plan to reflect and shape the thinking and enhance the health related decisions of scientists, experts, governments, and common society, corporates and United Nations agencies. The objective is to investigate enriching the human services through an interdisciplinary approach. It reflects our belief that in order to facilitate affordable & accessible healthcare delivery, one have to stay with developments in other disciplines in this very well developed & knowledgeable world. Public Health Congress 2017 is therefore a stage towards forging new dialogues with various stakeholders of Public health community beyond in Asian, European and USA Countries, acquiring new experiences and points of view from different fields, offering a stage on which to cultivate scholarly research among all partners and above all being the instrument of worldwide advances in health care.

Session 13: Modern Public Health Practices

Public health is a part of the infrastructure that maintains our community healthy and safe. It is concerned with threats to health based totally on population health evaluation. The awareness of public health intervention is to enhance fitness and exceptional of existence via prevention and remedy of disease and other physical and mental fitness conditions.

Market Analysis

This Conference will provide a perfect platform to all the International mix of leading Research Scholars, and Scientists achieved eminence in their field of study, research academicians from the universities and research institutions, industrial research professionals and business associates along with PhD Students to come and inform all the attendees about the latest scientific advancements on the respective sphere. The global personalized medicine in the market was valued at USD 1,007.88 billion in 2018 and is expected to reach USD 2,452.50 billion in 2022, growing at a CAGR of 11.8% over the forecast period. Key drivers of the market include growing development of next-generation sequencing, whole genome technology, companion diagnostics and the growing number of retail clinics. Growing healthcare expenditure levels triggering the need for an effective diagnostic procedure for cancer, the growing prevalence of cancer and increasing usage of combination biomarkers for diagnostics are few factors expected to boost market growth. Increasing adoption of next-generation sequencing for genetic mapping of patients by clinicians and medical practitioners worldwide and growing support for personalized medicine by reimbursement and regulatory landscape are also factors expected to drive demand through to 2022. Market growth is also expected to rise through the novel introduction of drugs with associated and companion diagnostics, and growing usage of highly sensitive, accurate genetic diagnostic techniques for disease testing and risk assessment. Anticipated increase in advanced DNA diagnostic usage combined with the reduction in implementation costs for whole genome sequencing is expected to considerably increase penetration rates.

Past Conference Report

Euro Personalized Medicine 2020

We gratefully thank all our wonderful Speakers, Conference Attendees, Students, Media Partners, Associations and Exhibitors for making Euro Personalized Medicine 2020 conference the best ever!

International conference Euro Personalized Medicine hosted by the Longdom Conference was held during May 19-20, 2020 Berlin, Germany based on the theme “Exploring Advances of COVID-19 in Personalized Medicine and Pharmacogenomics”

The conference was initiated with the Honourable presence of the Keynote forum. The list includes

Dr Sergio Marcucci, Luxembourg
Dr Rahul Hajare, India
Dr Amr Elnaggar, UAE
DR.ANIL BATTA , Govt.Medical College, India
Prof Magdy Abouzeid, Egypt

With the grand success of Euro Personalized Medicine 2020, Longdom Conferences is proud to announce the " 5th International Conference on Personalized Medicine And Novel Therapy" to be held Sep 09-10, 2024 Paris, France.

For More details, visit: https://www.longdom.com/personalizedmedicine

Global Summit On Personalized Medicine and Health Care 2021:

We gratefully thank all our wonderful Speakers, Conference Attendees, Students, Media Partners, Associations and Exhibitors for making Global Summit On Personalized Medicine and Health Care 2021 conference the best ever!

International conference Global Summit On Personalized Medicine and Health Care 2021 hosted by the Longdom Conference was held during Sep 01-02, 2021 Tokyo, Japan based on the theme “Discovering Development in Personalized Medicine and Public Health “Discovering Development in Personalized Medicine and Public Health”

The conference was initiated with the Honourable presence of the Keynote forum. The list includes:

Dr Atique Ahmed, France
Dr Sam Vaknin, Russia
Dr Lyzwinsk
i Lynnette Nathalie, UAE
Prof Frank Van De Goot, UK

With the grand success of Global Summit On Personalized Medicine and Health Care 2021, Longdom Conferences is proud to announce the " 5th International Conference on Personalized Medicine And Novel Therapy” to be held Sep 09-10, 2024 Paris, France

For More details, visit: https://www.longdom.com/personalizedmedicine

Global Summit On Personalized Medicine and Health Care 2022:

International conference Global Summit On Personalized Medicine and Health Care 2022 hosted by the Longdom Conference was held during Jul 25-26, 2022 Rome, Italy based on the theme “Discovering Development in Personalized Medicine and Health Care”

The conference was initiated with the Honourable presence of the Keynote forum.

With the grand success of Global Summit On Personalized Medicine and Health Care 2022, Longdom Conferences is proud to announce the " 5th International Conference on Personalized Medicine And Novel Therapy” to be held Sep 09-10, 2024 Paris, France

For More details, visit: https://www.longdom.com/personalizedmedicine

3^rd Euro Conference On Personalized Medicine and Pharmacogenomics 2022:

We gratefully thank all our wonderful Speakers, Conference Attendees, Students, Media Partners, Associations and Exhibitors for making 3rd Euro Conference On Personalized Medicine and Pharmacogenomics 2022conference the best ever!

International conference Euro On Personalized Medicine and Pharmacogenomics hosted by the Longdom Conference was held during Sep 05-06, 2022 London, UK based on the theme “Investigating Current Challenges in Sports Medicine and Rehabilitation”

The conference was initiated with the Honourable presence of the Keynote forum. The list includes:

Dr Nasibova, Russia
Dr Lichun Xie, China
Dr Sergey Suchkov, Russia

With the grand success of 3rd Euro Conference On Personalized Medicine and Pharmacogenomics 2022, Longdom Conferences is proud to announce the " 5th International Conference on Personalized Medicine and Novel Therapy” to be held Sep 09-10, 2024 Paris, France

For More details, visit: https://www.longdom.com/personalizedmedicine

Abstracts enquiry

Registration enquiry

Contact Enquiry

Phone

WhatsApp

Useful Links

News

Cancer Patients Gain Important Benefits from Genome-Matched Treatments

December 12, 2023 Customizing mRNA is easy, and that’s what makes it the next frontier for personalized medicine ? a molecular biologist explains

Newsletter

About

Personalized Medicine and Novel Therapy

Cancer Patients Gain Important Benefits from Genome-Matched Treatments

December 12, 2023 Customizing mRNA is easy, and that’s what makes it the next frontier for personalized medicine ? a molecular biologist explains